|
|
Other links at Articles > Cardiology |
| 3. |
NAVIGATOR Off Course to Diabetes Prevention With Valsartan, Nateglinide
|
|
|
In a population with impaired glucose tolerance and CV disease or risk factors, the angiotensin receptor blocker had a slight effect and the short-acting insulin secretagogue had no favorable impact on progression to diabetes; neither drug prevented cardiovascular events. Heartwire
|
|
|